The potential role of COVID-19 in the induction of DNA damage<br><a href="https://www.sciencedirect.com/science/article/pii/S1383574222000011?via%3Dihub" target="_blank" rel="noopener nofollow">https://www.sciencedirect.com/science/article/pii/S1383574222000011?via%3Dihub</a><br><br>S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study<br><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324311/" target="_blank" rel="noopener nofollow">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324311/</a><br><br>Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer<br><a href="https://jamanetwork.com/journals/jama/fullarticle/2787650" target="_blank" rel="noopener nofollow">https://jamanetwork.com/journals/jama/fullarticle/2787650</a><br><br>Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccination<br><a href="https://onlinelibrary.wiley.com/doi/10.1111/jdv.18136" target="_blank" rel="noopener nofollow">https://onlinelibrary.wiley.com/doi/10.1111/jdv.18136</a><br><br>Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature<br><a href="https://pubmed.ncbi.nlm.nih.gov/36676781/" target="_blank" rel="noopener nofollow">https://pubmed.ncbi.nlm.nih.gov/36676781/</a><br><br>B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report<br><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183601/" target="_blank" rel="noopener nofollow">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183601/</a><br><br><span style="color: red;">クリエイターサポート</span><br><a href="https://creator-support.nicovideo.jp/registration/65066712?ref=pc_userpage" target="_blank" rel="noopener nofollow">https://creator-support.nicovideo.jp/registration/65066712?ref=pc_userpage</a>
6:11
